Use of relaxin in cardiovascular therapy
US5166191A · kind A · utility
41Cited by
5References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1991 |
| Grant date | Nov 24, 1992 |
| Priority date | — |
| Expiry date | Aug 19, 2011 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/72
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns the use of relaxin in the cardiovascular therapy, and specifically in the treatment of acute and chronic heart failure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.